FDA Investigator Jean Blackstone Hill
Jean Blackstone Hill has inspections in 1 countries as of 06 Oct 2023. Jean Blackstone Hill has collaborated with a combined 2235 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
7
Last Inspection Date:
06 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Amy L Singer,
Andrace Lde Yampert,
Andrea D Swingle,
Anita R Michael,
Audrey Thereset Uy,
Bei Y He,
Benjamin J Smith,
Byungja E Marciante,
Charles I Ann,
Charles L Zhou,
Charles M Edwards,
Colleen M Damon,
Constantin Y Philopoulos,
Corrine M Carter,
Craig D Zagata,
Daniel J Grabicki,
David A Paterson,
David J Hafner,
Dawn L Wydner,
Debara R Reese,
Debara Reese,
Debra J Bennett,
Denise L Burosh,
Denise M Digiulio,
Dennis E Guilfoyle, PhD,
Dina A Tallman,
Djamila Harouaka,
Donald C Obenhuber, PhD,
Emest F Bizjak,
Emily J Orban,
Emmanuel J Ramos,
Erin D Mccaffery,
Frederick Razzaghi,
Gayle S Lawson,
Gianine E Tompkins,
Jaison J Eapen,
James C Illuminati,
James R Birkenstamm,
Jean Blackston Hill,
Jeffrey A Sommers,
Jeffrey D Meng,
Jennifer A Kemp,
Joanne Heim,
Joanne M Hajoway,
Jogy George,
Jose M Cayuela,
Joseph A Piechocki,
Joseph R Strelnik,
Joy Rkozlowski Klena,
Julianne C Mccullough,
Jullianne C Mccullough,
Justine Tomasso,
Karen E D'orazio,
Karen M Montgomery (KMM),
Karyn M Campbell,
Kristen D Evans,
Kristina J Donohue,
Kristina L Conroy,
Kristina Mjoyce Pittman,
L'oreal F Walker,
Larry K Austin,
Lauren Iacono Connors, PhD,
Lawrence Harmon, Jr,
Leigh Anne Myers,
Liatte Kreuger, PharmD,
Lisa B Orr,
Lisa M Bellows,
Luella J Rossi,
Luis A Dasta,
Marea K Harmon,
Maria Estrella,
Matthew R Noonan,
Meisha R Sampson,
Meisha Waters,
Melina Rodriguez Upton,
Mercy Oyugi,
Michael A Taylor,
Michael Gurbarg,
Michael L Casner,
Michael R Klapal,
Michael Shanks, MS,
Michele L Forster, PhD,
Montgomery Montgomery, Karen M,
Muna Algharibeh,
Myra K Casey,
Nailing Zhang,
Neali H Lucas,
Niketa Patel,
Patricia A Cochran,
Patricia H Dlugosz,
Patrick B Cummings,
Patsy J Domingo,
Paul L Bellamy,
Qiao Y Bobo,
Rafeeq A Habeeb,
Raymond T Oji,
Rebecca E Dombrowski,
Regina T Brown,
Richard J Muzeni,
Robert B Shibuya, MD,
Robert D Tollefsen,
Robert J Ham,
Robert J Maffei,
Robert M Barbosa,
Sam Pepe,
Sandra A Boyd,
Sharon K Thoma, PharmD,
Stephen J Koniers,
Stephen J Mottola,
Susan F Laska, MS,
Susan P Bruederle,
Suyang Qin,
Tammy L Chavis,
Temar Q Williams,
Thomas E Friel,
Thomas J Arista,
Thuy T Nguyen, LCDR,
Tina M Pawlowski,
Vlada Matusovsky,
Wayne E Seifert,
William D Tingley,
Yangmin Ning,
Yumi J Hiramine,
Yvesna C Blaise
Jean Blackstone Hill's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2001 | EIR | Noramco, LLC - EIR, 2001-05-08 |
October, 2001 | FDA 483 Response | Scientech Laboratories, Inc. - Form 483R, 2001-11-29 |
May, 2002 | FDA 483 | Eli Lilly and Company - Form 483, 2002-05-30 |
May, 2001 | FDA 483 | Noramco, LLC - Form 483, 2001-05-08 |
October, 2001 | FDA 483 | Scientech Laboratories, Inc. - Form 483, 2001-10-31 |
May, 2002 | FDA 483 Response | Eli Lilly and Company - Form 483R, 2002-05-30 |
May, 2002 | EIR | Eli Lilly and Company - EIR, 2002-05-30 |
July, 2001 | FDA 483 | Intertek USA, Inc. - Form 483, 2001-07-25 |
December, 2000 | FDA 483 | Frontida BioPharm, LLC - Form 483, 2000-12-08 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more